Immunogenicity 14153
Sample ID
3784
Response
Negative
Tumor Type
Melanoma
Gene Symbol
CD164
Transcript ID
NM_006016
HLA INFO
C*07:02
TCR INFO
No TCR info found!
Full length protein sequence (197 aa)
MSRLS
1
RSLLW
6
AATCL
11
GVLCV
16
LSADK
21
NTTQH
26
PNVTT
31
LAPIS
36
NVTSA
41
PVTSL
46
PLVTT
51
PAPET
56
CEGRN
61
SCVSC
66
FNVSV
71
VNTTC
76
FWIEC
81
KDESY
86
CSHNS
91
TVSDC
96
QVGNT
101
TDFCS
106
VSTAT
111
PVPTA
116
NSTAK
121
PTVQP
126
SPSTT
131
SKTVT
136
TSGTT
141
NNTVT
146
PTSQP
151
VRKST
156
FDAAS
161
FIGGI
166
VLVLG
171
VQAVI
176
FFLYK
181
FCKSK
186
ERNYH
191
TL
196
Mutation Information
DNA mutation:
None
Peptide Range:
38 ~ 62
Mut AA position:
50 (13 in Wild Type peptide)
Alignment
Wild Type:
"PISNVTSAPVTSLPLVTTPAPETCE
||||||||||||.||||||||||||
Mutant:
PISNVTSAPVTSPPLVTTPAPETCE"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) CD164
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay